Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Royaume-Uni (3)
Organization / System Development
Musculoskeletal/Multiple Sclerosis (MS) (1)
Biotech Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase III